Robert Broughton, MD
Internal Medicine · Fort Gordon, GANPI 1386909034
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by AbbVie at 31.9% of the total. Reporting peaked in 2023 at $192 and has fallen 79.0% since, to $40 in 2024.
Across 33 payments — averaging $17.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$180
- Pfizer$126
- AstraZeneca$93
- Johnson & Johnson$57
- E.r. Squibb & Sons, L.L.C.$36
- Lexicon Pharmaceuticals, Inc.$35
- plus $40 from 2 others
What the payments were for
- Food & beverage$566100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 11 | $180 |
| Pfizer | 7 | $126 |
| AstraZeneca | 6 | $93 |
| Johnson & Johnson | 3 | $57 |
| E.r. Squibb & Sons, L.L.C. | 2 | $36 |
| Lexicon Pharmaceuticals, Inc. | 2 | $35 |
| Novartis | 1 | $27 |
| Aurinia Pharma U.S., Inc. | 1 | $14 |
How this compares
$566 in reported general payments places this provider in the 60th percentile of 3,311 internal medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 13 | $10,794 |
| Levothyroxine Sodium | 28 | $463 |
| Duloxetine Hcl | 15 | $380 |
| Spironolactone | 11 | $219 |
| Atorvastatin Calcium | 30 | $201 |
| Pantoprazole Sodium | 17 | $124 |
| Amlodipine Besylate | 16 | $84 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Fort Gordon
- Michael GibsonSmyrna$2.2M
- Eduard FatakhovAlpharetta$376K
- Tracey HenryAtlanta$305K
- Sharon TuckettVilla Rica$265K
- Ebon BourneMarietta$242K
- Jennifer WoehlerSavannah$207K
- Julian HutchinsGreensboro$201K
- Brian PearlmanDalton$199K
- Scott ParryAtlanta$162K
- Jennifer GilliganAtlanta$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.